Sanofi Shines, Bayer Brighter, AZ Loses Leadership: China Roundup
This article was originally published in PharmAsia News
Multinational pharmaceutical players in China are recovering in the aftermath of a drastic slowdown in the country, growing on average by 4% in the last quarter, although one leading company quadrupled that figure. PharmAsia News has combed through earnings reports to bring you the winners, laggards and most successful strategies among major global firms in China.
Register for our free email digests: